{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:07:24Z","timestamp":1791050844125,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/cco.0b013e32834f5c27","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T05:55:15Z","timestamp":1324360515000},"page":"191-196","source":"Crossref","is-referenced-by-count":56,"title":["Allogeneic transplantation"],"prefix":"10.1097","volume":"24","author":[{"given":"William I.","family":"Bensinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/0140-6736(93)90929-B","article-title":"Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation.","volume":"341","author":"Russell","year":"1993","journal-title":"Lancet"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V85.6.1413.bloodjournal8561413","article-title":"Peripheral blood stem cells for allografting.","volume":"85","author":"Goldman","year":"1995","journal-title":"Blood"},{"key":"R3-14-20210128","first-page":"353","article-title":"Peripheral blood stem cells for allogeneic transplantation.","volume":"13","author":"Russell","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","article-title":"Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.","volume":"85","author":"Korbling","year":"1995","journal-title":"Blood"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","article-title":"Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor).","volume":"85","author":"Schmitz","year":"1995","journal-title":"Blood"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V85.6.1655.bloodjournal8561655","article-title":"Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.","volume":"85","author":"Bensinger","year":"1995","journal-title":"Blood"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/stem.140090","article-title":"Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.","volume":"14","author":"Bensinger","year":"1996","journal-title":"Stem Cells"},{"key":"R8-14-20210128","first-page":"40","article-title":"Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors.","volume":"80","author":"Majolino","year":"1995","journal-title":"Haematologica"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V88.7.2794.bloodjournal8872794","article-title":"Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation.","volume":"88","author":"Bensinger","year":"1996","journal-title":"Blood"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1182\/blood.V88.11.4132.bloodjournal88114132","article-title":"Transplantation of allogeneic CD34 peripheral blood stem cells in patients with advanced hematologic malignancy.","volume":"88","author":"Bensinger","year":"1996","journal-title":"Blood"},{"key":"R11-14-20210128","first-page":"703","article-title":"Allogeneic blood cell transplants for haematological malignancy: comparison of engraftment and graft-versus-host disease with bone marrow transplantation.","volume":"17","author":"Russell","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1700692","article-title":"Allogeneic blood stem cell transplantation in advanced hematologic cancers.","volume":"19","author":"Przepiorka","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R13-14-20210128","first-page":"647","article-title":"Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematologic malignancies.","volume":"16","author":"Azevedo","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood.V88.8.2819.bloodjournal8882819","article-title":"Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals.","volume":"88","author":"Anderlini","year":"1996","journal-title":"Blood"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/stem.140185","article-title":"Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts.","volume":"14","author":"Korbling","year":"1996","journal-title":"Stem Cells"},{"key":"R16-14-20210128","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation.","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1701866","article-title":"Blood and marrow transplantation activity in Europe 1997 (Special Report).","volume":"24","author":"Gratwohl","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/bmt.2011.11","article-title":"The EBMT activity survey 2009: trends over the past 5 years.","volume":"46","author":"Baldomero","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle.","volume":"18","author":"Blaise","year":"2000","journal-title":"J Clin Oncol"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.bmt.1702422","article-title":"A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.","volume":"25","author":"Heldal","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","article-title":"A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies.","volume":"22","author":"Vigorito","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R22-14-20210128","first-page":"665","article-title":"A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update.","volume":"86","author":"Vigorito","year":"2001","journal-title":"Haematologica"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701906","article-title":"Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation.","volume":"24","author":"Mahmoud","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncol"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V118.21.319.319","article-title":"Transplantation of peripheral blood cells as compared with bone marrow from HLA-identical related donors is associated with superior long-term outcomes.","volume":"118","author":"Mielcarek","year":"2011","journal-title":"Blood"},{"key":"R30-14-20210128","first-page":"2608","article-title":"Marrow transplantation for leukemia and aplastic anemia: Two controlled trials of a combination of methotrexate and cyclosporine versus cyclosporine alone or methotrexate alone for prophylaxis of acute graft-versus-host disease.","volume":"19","author":"Storb","year":"1987","journal-title":"Transplant Proc"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"R32-14-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705488","article-title":"Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.","volume":"38","author":"Bensinger","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V94.2.455","article-title":"Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.","volume":"94","author":"Ringden","year":"1999","journal-title":"Blood"},{"key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V118.21.1.1","article-title":"Increased incidence of chronic graft-versus-host disease (GVHD) and no survival advantage with filgastrim-mobilized peripheral blood stem cells (PBSC) compared to bone marrow (BM) transplants from unrelated donors: results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0201, a phase III prospective randomized trial.","volume":"118","author":"Anasetti","year":"2011","journal-title":"Blood"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bmt.1701386","article-title":"Allogeneic transplantation of selected CD34 cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.","volume":"22","author":"Urbano-Ispizua","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbmt.2011.02.002","article-title":"Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the Blood and Marrow Transplant Clinical Trials Network protocol 0303.","volume":"17","author":"Devine","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bbmt.2011.01.005","article-title":"T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.","volume":"17","author":"Jakubowski","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0301-472X(03)00195-4","article-title":"A randomized multicenter comparison of CD34()-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.","volume":"31","author":"Cornelissen","year":"2003","journal-title":"Exp Hematol"},{"key":"R41-14-20210128","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1083-8791(00)70034-6","article-title":"Long-term follow-up after allogeneic granulocyte colony-stimulating factor-primed bone marrow transplantation.","volume":"6","author":"Isola","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R42-14-20210128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1083-8791(00)70035-8","article-title":"Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.","volume":"6","author":"Serody","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R43-14-20210128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1083-8791(00)70033-4","article-title":"Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients.","volume":"6","author":"Couban","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R44-14-20210128","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1182\/blood.V98.12.3186","article-title":"Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.","volume":"98","author":"Morton","year":"2001","journal-title":"Blood"},{"key":"R45-14-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-0012.2010.01298.x","article-title":"Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.","volume":"25","author":"Chang","year":"2011","journal-title":"Clin Transplant"},{"key":"R46-14-20210128","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","article-title":"Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkins lymphoma.","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"key":"R47-14-20210128","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"R48-14-20210128","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood-2007-12-130179","article-title":"Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4SDF-1 interaction.","volume":"112","author":"Devine","year":"2008","journal-title":"Blood"},{"key":"R49-14-20210128","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.","volume":"15","author":"Pidala","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0b013e32834f5c27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:37:36Z","timestamp":1621885056000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201203000-00014"}},"subtitle":["peripheral blood vs. bone marrow"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e32834f5c27","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}